Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARVINAS, INC.ARVN · Entity 5355 | Director | June 25, 2025 | June 27, 2025 |
| Johnson Controls International plcJCI · Entity 2940 | Director | March 04, 2026 | March 06, 2026 |
| PFIZER INCPFE · Entity 2863 | Group President | December 15, 2021 | December 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARVINAS, INC.
Report date June 25, 2025 · Filed June 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,045 |
Reported balance
After 2025-06-25 transaction · row 1
1 source rowRow 1 · 2025-06-25 · Grant · Acquired 16,025 · Balance 26,045 F1: The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.80 · Expires 2035-06-24 | Direct | 23,105 |
Reported balance
After 2025-06-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-25 · Grant · Acquired 23,105 · Balance 23,105 F2: This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.
F2: This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.
Johnson Controls International plc
Report date March 04, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 18,271.58 |
Reported balance
After 2026-03-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-04 · Grant · Acquired 1,285 · Balance 18,271.58 F1: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 17,156.58 |
Reported balance
After 2026-03-04 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-04 · Tax withholding · Disposed 1,115 · Balance 17,156.58 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting.
PFIZER INC
Report date December 15, 2021 · Filed December 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 53,635 |
Reported balance
After 2021-12-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-12-15 · Grant · Acquired 8 · Balance 53,635 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2026 Filed Mar 6, 2026 21:36 UTC | Johnson Controls International plc JCI · Entity 2940 | Tax withholdingOrdinary Shares | 1,115 | $140.00 | $156,100.00 |
DisclosureSEC source: 0000897069-26-000608 · form4.xml · nonDerivative · entry 2 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,156.58 Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:36 UTC | Johnson Controls International plc JCI · Entity 2940 | GrantOrdinary Shares | 1,285 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-26-000608 · form4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,271.58 F1 · security: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. F1 · kind: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:13 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 23,105 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001655759-25-000120 · wk-form4_1751073197.xml · derivative · entry 2 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,105 Underlying: Common Stock · 23,105 shares Expires 2035-06-24 F2 · derivative.exercise_date: This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 21:13 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantCommon Stock | 16,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001655759-25-000120 · wk-form4_1751073197.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,045 F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 18:56 UTC | Johnson Controls International plc JCI · Entity 2940 | Tax withholdingOrdinary Shares | 1,416 | $78.68 | $111,410.88 |
DisclosureSEC source: 0001127602-25-009417 · form4.xml · nonDerivative · entry 2 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,828.56 F1 · security: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 18:56 UTC | Johnson Controls International plc JCI · Entity 2940 | GrantOrdinary Shares | 2,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-009417 · form4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,244.56 F1 · security: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. F1 · kind: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. Read SEC document |
| May 29, 2024 Filed May 31, 2024 17:51 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 9,070 | $0.00 Strike: $33.90 | $0.00 |
DisclosureSEC source: 0001655759-24-000082 · wk-form4_1717192266.xml · derivative · entry 2 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,070 Underlying: Common Stock · 9,070 shares Expires 2034-05-28 F2 · derivative.exercise_date: This option award was granted on May 29, 2024. The shares underlying the award shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders. Read SEC document |
| May 29, 2024 Filed May 31, 2024 17:51 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantCommon Stock | 5,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001655759-24-000082 · wk-form4_1717192266.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,020 F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders. Read SEC document |
| March 13, 2024 Filed Mar 14, 2024 23:19 UTC | Johnson Controls International plc JCI · Entity 2940 | GrantOrdinary Shares | 2,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-010201 · form4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,700.82 F1 · shares: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. Read SEC document |
| March 09, 2024 Filed Mar 11, 2024 21:44 UTC | Johnson Controls International plc JCI · Entity 2940 | Tax withholdingOrdinary Shares | 1,401 | $61.73 | $86,483.73 |
DisclosureSEC source: 0001127602-24-009435 · form4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,811.82 Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 17:29 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 12,787 | $0.00 Strike: $30.33 | $0.00 |
DisclosureSEC source: 0001655759-23-000068 · wk-form4_1687296539.xml · derivative · entry 2 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,787 Underlying: Common Stock · 12,787 shares Expires 2033-06-14 F2 · derivative.exercise_date: This option award was granted on June 15, 2023. The shares underlying the award shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 17:29 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantCommon Stock | 4,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001655759-23-000068 · wk-form4_1687296539.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,121 F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on June 15, 2023 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 19:11 UTC | Johnson Controls International plc JCI · Entity 2940 | GrantOrdinary Shares | 2,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009841 · form4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,874.82 F1 · shares: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:10 UTC | Johnson Controls International plc JCI · Entity 2940 | Exercise / conversionOrdinary Shares | 1,372 | $63.46 | $87,067.12 |
DisclosureSEC source: 0001127602-23-009648 · form4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,031.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 17:02 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 24,572 | $0.00 Strike: $46.12 | $0.00 |
DisclosureSEC source: 0001655759-22-000042 · wf-form4_166120212293775.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,572 Underlying: Common Stock · 24,572 shares Expires 2032-08-17 F1 · derivative.exercise_date: This option award was granted on August 18, 2022. The shares underlying the award shall vest in equal monthly installments through August 18, 2025. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 18:12 UTC | Johnson Controls International plc JCI · Entity 2940 | Tax withholdingOrdinary Shares | 1,398 | $62.81 | $87,808.38 |
DisclosureSEC source: 0001127602-22-008979 · form4.xml · nonDerivative · entry 2 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,109.8 Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 18:12 UTC | Johnson Controls International plc JCI · Entity 2940 | GrantOrdinary Shares | 2,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008979 · form4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,507.8 F1 · shares: Reflects grant of restricted share units. Restricted share units accrue dividend equivalent units and convert to ordinary shares upon vesting. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 23:05 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 8 | $58.80 | $470.40 |
DisclosureSEC source: 0001225208-21-015081 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,635 Underlying: Common Stock · 8 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2021 Filed Dec 1, 2021 21:50 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 8 | $53.73 | $429.84 |
DisclosureSEC source: 0001225208-21-014282 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,645 Underlying: Common Stock · 8 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 22:37 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 9 | $49.65 | $446.85 |
DisclosureSEC source: 0001225208-21-013903 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,698 Underlying: Common Stock · 9 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 47,782 | $50.01 | $2,389,577.82 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 11 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,704 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 30,200 | $50.02 | $1,510,604.00 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 10 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,486 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 15,500 | $50.12 | $776,860.00 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 9 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,686 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 11,700 | $50.10 | $586,170.00 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 8 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,186 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 9,818 | $50.07 | $491,587.26 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 7 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,886 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 9,500 | $50.15 | $476,425.00 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 6 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,704 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 9,100 | $50.14 | $456,274.00 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 5 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,204 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 6,200 | $50.06 | $310,372.00 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 4 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,304 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 4,200 | $50.03 | $210,126.00 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 3 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,504 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 3,200 | $50.09 | $160,288.00 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 2 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,704 Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:08 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 2,800 | $50.16 | $140,448.00 |
DisclosureSEC source: 0001225208-21-013850 · doc4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,904 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 15:46 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 10 | $43.74 | $437.40 |
DisclosureSEC source: 0001225208-21-013419 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,316 Underlying: Common Stock · 10 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 22:47 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 11 | $41.49 | $456.39 |
DisclosureSEC source: 0001225208-21-013133 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,329 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 12, 2021 Filed Oct 13, 2021 19:46 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 36 | $41.85 | $1,506.60 |
DisclosureSEC source: 0001225208-21-013101 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,315 Underlying: Common Stock · 36 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 19:43 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 10 | $43.01 | $430.10 |
DisclosureSEC source: 0001225208-21-012643 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,271 Underlying: Common Stock · 10 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 22:10 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 10 | $44.77 | $447.70 |
DisclosureSEC source: 0001225208-21-012431 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,249 Underlying: Common Stock · 10 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 20:03 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 10 | $46.07 | $460.70 |
DisclosureSEC source: 0001225208-21-011910 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,238 Underlying: Common Stock · 10 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 00:13 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 9 | $48.48 | $436.32 |
DisclosureSEC source: 0001225208-21-011505 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,194 Underlying: Common Stock · 9 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 30, 2021 Filed Aug 2, 2021 23:03 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 10 | $42.81 | $428.10 |
DisclosureSEC source: 0001225208-21-011036 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,291 Underlying: Common Stock · 10 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:13 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 11 | $40.09 | $440.99 |
DisclosureSEC source: 0001225208-21-010711 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,834 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 19:49 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 38 | $39.65 | $1,506.70 |
DisclosureSEC source: 0001225208-21-010644 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,827 Underlying: Common Stock · 38 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 20:10 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 11 | $39.16 | $430.76 |
DisclosureSEC source: 0001225208-21-009914 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,798 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 18:01 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 11 | $39.59 | $435.49 |
DisclosureSEC source: 0001225208-21-009459 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,785 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 19:34 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 11 | $38.73 | $426.03 |
DisclosureSEC source: 0001225208-21-008703 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,791 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:43 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 11 | $40.02 | $440.22 |
DisclosureSEC source: 0001225208-21-008216 · doc4.xml · derivative · entry 4 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,751 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 07, 2021 Filed May 17, 2021 20:43 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 8,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-008216 · doc4.xml · nonDerivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,761 Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:32 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 11 | $38.65 | $425.15 |
DisclosureSEC source: 0001225208-21-007395 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,247 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 21:51 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 12 | $37.60 | $451.20 |
DisclosureSEC source: 0001225208-21-006821 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,245 Underlying: Common Stock · 12 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 21:35 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 223 | $36.97 | $8,244.31 |
DisclosureSEC source: 0001225208-21-006739 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,239 Underlying: Common Stock · 223 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 21:49 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 12 | $36.23 | $434.76 |
DisclosureSEC source: 0001225208-21-006236 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,021 Underlying: Common Stock · 12 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.